NXNL1 Polyclonal Antibody (E-AB-52711)
For research use only.
| Verified Samples |
Verified Samples in IHC: Human cervical cancer, Human esophagus cancer |
| Dilution | IHC 1:30-1:150 |
| Isotype | IgG |
| Host | Rabbit |
| Reactivity | Human |
| Applications | IHC |
| Clonality | Polyclonal |
| Immunogen | Fusion protein of human NXNL1 |
| Abbre | NXNL1 |
| Synonyms | NXNL1, Nucleoredoxin like 1, Nucleoredoxin-like protein 1, Nxnl1, RDCVF, Rod derived cone viability factor, Thioredoxin like 6, Thioredoxin-like protein 6 |
| Swissprot | |
| Concentration | 0.78 mg/mL |
| Buffer | Phosphate buffered solution, pH 7.4, containing 0.05% stabilizer and 50% glycerol. |
| Purification Method | Antigen affinity purification |
| Research Areas | Cell Biology, Metabolism |
| Conjugation | Unconjugated |
| Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
| Shipping | The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended. |
| background | Retinitis pigmentosa (RP) is a disease that leads to blindness by degeneration of cone photoreceptors.Rods produce factors required for cone viability.The protein encoded by this gene is one of those factors and is similar to a truncated form of thioredoxin.This gene has been proposed to have therapeutic value against RP. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
-
IF：{{item.impact}}
Journal：{{item.journal}} ({{item.year}})
DOI：{{item.doi}}Reactivity：{{item.species}}
Sample Type：{{item.organization}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
